[Interest of confocal endomicroscopy for the management of chronic inflammatory bowel disease].

Autor:	Loly JP; Service de gastroentérologie, hépatologie et oncologie digestive, CHU de Liège, 4000 Liège, Belgique., Somja J; Service d'anatomopathologie, CHU de Liège, 4000 Liège, Belgique., Reenaers C; Service de gastroentérologie, hépatologie et oncologie digestive, CHU de Liège, 4000 Liège, Belgique., Van Kemseke C; Service de gastroentérologie, hépatologie et oncologie digestive, CHU de Liège, 4000 Liège, Belgique., Gast P; Service de gastroentérologie, hépatologie et oncologie digestive, CHU de Liège, 4000 Liège, Belgique., Louis E; Service de gastroentérologie, hépatologie et oncologie digestive, CHU de Liège, 4000 Liège, Belgique.
Jazyk:	francouzština
Zdroj:	Revue medicale suisse [Rev Med Suisse] 2017 Aug 23; Vol. 13 (571), pp. 1431-1434.
Abstrakt:	Inflammatory bowel diseases are chronic diseases whose long-term evolution depends on the depth of remission. Their clinical and endoscopic evaluation is imperfect. The development of confocal endomicroscopy allows microscopic images to be obtained in vivo. These microscopic data are correlated with the activity of the disease. They predict a possible relapse of the disease and also predict the response to treatment with a biological agent, which allows to modify the therapy before the relapse or to make a rational choice between the different biological agents before introducing a new treatment. Competing Interests: Les auteurs n’ont déclaré aucun conflit d’intérêts en relation avec cet article.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu